Ben Wolff, CEO of Sarcos® Robotics, the global leader in developing full body powered exoskeletons for work, industry, and logistics announced at WearRAcon18 the formation of the Exoskeleton Technical Advisory Group, X-TAG. X-TAG is an industry focused collaborative effort comprised of executives from companies representing a broad range of [more]
The Honda Walking Assist Device has earned the European Union (EU) CE certification mark for medical devices. This allows the Honda Motor Company to market and commercialize its wearable robot as a medical device in EU countries and signifies conformity with EU standards. The Honda Walking Assist Device is an assistive powered hip exoskeleton [more]
Up until just a few years ago, the world of exoskeletons was dominated by large, heavy, multi-actuator, and complex exoskeletons. When someone talked about wearable robots, it was immediately understood that it will have a significant physical presence. Rather than becoming larger, general exoskeleton development took a sharp turn in the [more]
Lockheed Martin (NYSE: LMT) has licensed the Dermoskeleton™ technology from B-Temia, Inc. This is the same technology that runs the Keeogo lower body exoskeleton. Lockheed Martin hopes to integrate the powered exoskeleton technology and apply it to its current product, the FORTIS, and as of yet unreleased products. The FORTIS is a passive [more]
EduExo is on track to become the first commercially available robotic exoskeleton kit for STEM (science technology engineering and mathematics) education. The EduExo Kickstarter was approved as an all-or-nothing project, meaning it will not be funded unless it reaches the project goal by June 7th, 2017. Luckily, you now have the opportunity to [more]
There are currently a dozen exoskeleton companies that are publicly traded. They are: Activelink/Panasonic Bionik Laboratories Cyberdyne Ekso Bionics Honda Hyundai Lockheed Martin Parker Hannifin Rewalk Robotics Samsung Toyota REX Bionics For a quick investment centered overview of each, see Nanalyze: 9 Robotic Exoskeleton Stocks For Investors [more]
C-Suite TV with Jeffery Hayzlett has published an interview with Ekso Bionics CFO Max Scheder-Bieschin. In the interview, Max Scheder-Bieschin focuses on the current and future medical exoskeleton offerings by Ekso Bionics. However, his thoughts and opinions have many overarching ideas that can be applied to all medical exoskeletons as well [more]
The maker of the mobile assistive arm exoskeleton MyomoPro has entered into an exclusive global distribution agreement with Ottobock. Ottobock is a giant in the world of prosthetics and orthotics with over 90 years of experience in the business. According to its corporate website, Ottobock’s four divisions: Prosthetics, Orthotics, [more]
The nonprofit organization, Parent Project Muscular Dystrophy has awarded a $600,000 grant to the New Jersey Insititute of Technology and Talem Technologies. The grant is focused on a two-year study on prolonging independence for children and adults suffering from Duchenne muscular dystrophy. The full article can be found on EurekAlert! PPMD [more]
Myomo, maker of the MyoPro arm assistive exoskeleton has announced a proposed IPO through new crowdfunding rules called Reg A+ and plan to list on the New York Stock Exchange. Myomo, Inc., is a Cambridge, MA medical robotics company specializing in myoelectric orthoses for people with neurological disorders that affect the upper extremity. [more]
Adam Rubenfire has written a very persuasive and informative article on the challenges of modern medical technology, such as exoskeleton technology, to be covered by insurance companies in the U.S. The article was published on Modern Healthcare, November 26th, 2016 and can be found on their website. The same article is also posted on their [more]
Barely a year and a half after the last one, Ekso Bionics finds itself again under siege from a short attack. Even though the new damaging litany is clearly labeled “Important Disclosure: The owners of TheStreetSweeper hold a short position in EKSO and stand to profit on any future declines in the stock price.” there was still a [more]
Active Bionics closes shop, Microsoft invests in Sarcos, CYBERDYNE suffers a short attack, a German court ruled exoskeletons should be covered by the insurer, and ReWalk Robotics gets sued. These are only some of the exoskeleton financial and regulation news from August and September 2016. Active Bionics Shuts Down @activebionics demonstrating [more]
Ekso Bionics CEO Thomas Looby had the honor of ringing the August 30th NASDAQ closing bell. Tom was joined by nearly the entire management team, as well as many other employees and exoskeleton ambassadors. Ekso Bionics is not the first exoskeleton company to ring the NASDAQ bell. Nearly two years ago, ReWalk Robotics rang the opening bell in [more]
Ekso Bionics, one of the first exoskeleton startups, has been uplisted to the NASDAQ Stock Market. This marks a giant step forward for Ekso Bionics and dozens of newer wearable robotics companies that are considering going public. Ekso Bionics is based in Richmond, CA. It has been developing able-body and rehabilitation exoskeletons for over [more]
NASA, General Motors and Bioservo enter into the ultimate alliance to bring power gloves to the workplace. For the exoskeleton field, this is the greatest alliance between theoretical science and commercial engineering for an industrial application. This is not the ProGlove (proglove.de) that made the news last month. The ProGlove is an IoT [more]
Even taking Brexit into consideration, Ekso Bionics and ReWalk Robotics, two of the largest publicly traded exoskeleton companies are trading at or near all time lows. This highlights that in the current climate it is difficult to invest in exoskeleton companies. Yesterday the publicly traded exoskeleton companies closed at: ReWalk Robotics [more]
The vast majority of exoskeleton companies are losing money leaving many investors to wonder when are we going to reach the inflection point? The exoskeleton industry inflection point is the time when the major companies in the field start turning a profit. Another side of the same question is the low number of exoskeleton sales. If the [more]
On May 17, 2016 Harvard University’s Wyss Institute and ReWalk Robotics announced a collaboration to develop an exosuit for patients with limited mobility. The soft exoskeleton will be used primarily for patients undergoing rehabilitation due to stroke or multiple sclerosis. There are also plans to develop the Wyss exosuit as a general [more]
One large step for ErgoSkeletons™, one even larger step for all exoskeletons. The V22 and FLx by StrongArm® Technologies have gone on sale on 3M’s website. This is the first time an exoskeleton has gone on sale on a major North American website. 3M is a titanic distributor and manufacturer with over 55,000 products, predominantly in the [more]
